# Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)

> **NCT04664075** · — · TERMINATED · sponsor: **Imperial College London** · enrollment: 8 (actual)

## Conditions studied

- Influenza
- SARS (Severe Acute Respiratory Syndrome)
- Respiratory Viral Infection
- Respiratory Tract Infections
- Infection, Bacterial
- Infection Viral
- Covid19
- RNA Virus Infections

## Interventions

- **BIOLOGICAL:** Respiratory infections

## Key facts

- **NCT ID:** NCT04664075
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-25
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** The study failed to recruit sufficient number of participants.
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04664075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04664075, "Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04664075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*